MedTrace Logo

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

NCT05505136 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2023-06-18

No results posted yet for this study

Summary

To determine the associations among biometric data and previously reported medication changes in the original MAPS study

Conditions

  • Cardiac Arrhythmia

Interventions

DEVICE

Arrhythmia Management System (AMS)

Retrospective collection of data related to subjects who participated in the MAPS 90D0234 study and had a medication change reported will wearing the AMS device.

Sponsors & Collaborators

  • Zoll Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Steven Ringquist · Zoll Services LLC

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-30
Primary Completion
2023-03-01
Completion
2023-05-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05505136 on ClinicalTrials.gov